Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as a therapy for the chronic lung condition. It may soon become the first-ever FDA-approved treatment for bronchiectasis.
from Top Health News -- ScienceDaily https://ift.tt/tXWoy0e
Subscribe to:
Post Comments (Atom)
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
At least 22 people were killed and 171 others injured on Sunday when one of Taiwan’s newer, faster trains derailed on a curve along a popula...
-
Prosecutors in Mexico have opened an investigation into former president Enrique Peña Nieto, who is accused of taking bribes in one of Latin...
No comments:
Post a Comment